Takayasu arteritis (TA) is a chronic, idiopathic, inflammatorydisease that primarily affects large vessels [1]. The management ofthis disorder is largely unresolved, since a large number of patientsfail to reach stable remission on conventional treatment. anti-TNF treatmentmay prove useful both for disease control and to avoid the risk oflong-term toxicity of corticosteroids and classical immunosuppressivedrugs in Takayasu arteritis.

Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent? / DELLA ROSSA, A; Tavoni, A; Merlini, G; Baldini, C; Sebastiani, Marco; Lombardi, M; Neglia, D; Bombardieri, S.. - In: RHEUMATOLOGY. - ISSN 1462-0324. - STAMPA. - 44:8(2005), pp. 1074-1075. [10.1093/rheumatology/keh661]

Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?

SEBASTIANI, Marco;
2005

Abstract

Takayasu arteritis (TA) is a chronic, idiopathic, inflammatorydisease that primarily affects large vessels [1]. The management ofthis disorder is largely unresolved, since a large number of patientsfail to reach stable remission on conventional treatment. anti-TNF treatmentmay prove useful both for disease control and to avoid the risk oflong-term toxicity of corticosteroids and classical immunosuppressivedrugs in Takayasu arteritis.
2005
44
8
1074
1075
Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent? / DELLA ROSSA, A; Tavoni, A; Merlini, G; Baldini, C; Sebastiani, Marco; Lombardi, M; Neglia, D; Bombardieri, S.. - In: RHEUMATOLOGY. - ISSN 1462-0324. - STAMPA. - 44:8(2005), pp. 1074-1075. [10.1093/rheumatology/keh661]
DELLA ROSSA, A; Tavoni, A; Merlini, G; Baldini, C; Sebastiani, Marco; Lombardi, M; Neglia, D; Bombardieri, S.
File in questo prodotto:
File Dimensione Formato  
Two Takayasu arteritis patients successfully treated with infliximab.pdf

Solo gestori archivio

Tipologia: Versione pubblicata dall'editore
Dimensione 73.21 kB
Formato Adobe PDF
73.21 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/609069
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 59
  • ???jsp.display-item.citation.isi??? 45
social impact